Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,801 GBX | +0.07% | +2.27% | +24.19% |
01:10pm | GSK : Deutsche Bank maintains a Buy rating | ZD |
11:06am | GSK : Receives a Buy rating from Jefferies | ZD |
Sales 2024 * | 31.61B 39.63B | Sales 2025 * | 33.56B 42.08B | Capitalization | 73.38B 92B |
---|---|---|---|---|---|
Net income 2024 * | 5.54B 6.95B | Net income 2025 * | 6.49B 8.14B | EV / Sales 2024 * | 2.71 x |
Net Debt 2024 * | 12.3B 15.43B | Net Debt 2025 * | 9.1B 11.41B | EV / Sales 2025 * | 2.46 x |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
11.4
x | Employees | 70,212 |
Yield 2024 * |
3.39% | Yield 2025 * |
3.51% | Free-Float | 94.38% |
Latest transcript on GSK plc
1 day | +0.07% | ||
1 week | +2.27% | ||
Current month | +7.65% | ||
1 month | +9.58% | ||
3 months | +9.70% | ||
6 months | +27.98% | ||
Current year | +24.19% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Hal Barron
BRD | Director/Board Member | 62 | 17-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.17% | 11 M€ | +0.83% | - | |
3.15% | 17 M€ | +6.60% | - | |
2.51% | 7 M€ | +7.65% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 1,801 | +0.07% | 933 333 |
24-05-10 | 1,800 | +1.07% | 9,331,038 |
24-05-09 | 1,780 | +0.39% | 6,397,742 |
24-05-08 | 1,774 | +0.71% | 6,684,171 |
24-05-07 | 1,761 | +1.59% | 14,302,770 |
Delayed Quote London S.E., May 13, 2024 at 06:57 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.19% | 91.83B | |
+30.38% | 684B | |
+29.55% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.19% | 240B | |
+9.45% | 208B | |
-7.16% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- GSK Stock